Acute Exacerbation of COPD and Nebulized Magnesium Sulphate

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Chronic Obstructive Pulmonary Disease ExacerbationMagnesium Sulfate
Interventions
DRUG

Nebulized Magnesium Sulphate

Group A received 250mg of MgSO4 /dose given through nebulizer four times a day, while group B did not. The groups will be followed for five days to see the results in terms of in-hospital outcome, whether the patient is discharged after fulfilling the set criteria or needing assisted ventilation.

Trial Locations (1)

54000

Fawad Ahmad Randhawa, Lahore

All Listed Sponsors
lead

King Edward Medical University

OTHER

NCT05699720 - Acute Exacerbation of COPD and Nebulized Magnesium Sulphate | Biotech Hunter | Biotech Hunter